These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19696981)

  • 21. Analysis of clinicopathological and immunohistochemical parameters and correlation of outcomes in gastrointestinal stromal tumors.
    Varshney VK; Gupta RK; Saluja SS; Tyagi I; Mishra PK; Batra VV
    Indian J Cancer; 2019; 56(2):135-143. PubMed ID: 31062732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microscopic gastrointestinal stromal tumours: a clinical and molecular study of 13 cases.
    Anderson W; O'Sullivan B; Hughes F; Swift C; Smith M; Deshmukh N; Taniere P
    Histopathology; 2017 Jan; 70(2):211-216. PubMed ID: 27472829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIT and PDGFRalpha mutational analyses of mixed cell-type gastrointestinal stromal tumours.
    Wong NA; Mangwana S
    Histopathology; 2007 Dec; 51(6):758-62. PubMed ID: 18042065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial gastrointestinal stromal tumor syndrome: report of 2 cases with KIT exon 11 mutation.
    Jones DH; Caracciolo JT; Hodul PJ; Strosberg JR; Coppola D; Bui MM
    Cancer Control; 2015 Jan; 22(1):102-8. PubMed ID: 25504284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastrointestinal stromal tumors: recommendations for diagnosis, treatment and aftercare in Austria].
    Ploner F; Zacherl J; Wrba F; Längle F; Bareck E; Eisterer W; Kühr T; Schima W; Häfner M; Brodowicz T;
    Wien Med Wochenschr; 2009; 159(15-16):370-82. PubMed ID: 19696980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immunohistochemical and molecular study of gastrointestinal stromal tumours.
    Teong YT; Teo ST; Tan LP; Wu BQ; Peh SC
    Med J Malaysia; 2006 Dec; 61(5):526-33. PubMed ID: 17623951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
    Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R
    Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenging differential diagnosis of a wild-type gastrointestinal stromal tumour (GIST) or rare reticular perineurioma of the stomach? The role for mutational analysis.
    Richter KK; Dempster A; Tos AP; Premkumar R; Jackson C
    N Z Med J; 2011 Mar; 124(1331):45-55. PubMed ID: 21725412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
    Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
    Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastrointestinal stromal tumors: a rare nosological entity and a model example for the use of personalized therapy with a molecular basis].
    Bettegazzi C; Erra S
    Recenti Prog Med; 2015 Jan; 106(1):52-7. PubMed ID: 25621782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
    Ding J; Sun P; Cai XY; Fei SH; Wu J; Qi YK; Liu ZB; Yuan L; He YJ; Song H; Chen WX
    Int J Clin Exp Pathol; 2014; 7(12):9076-80. PubMed ID: 25674291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemoperitoneum secondary to gastric GIST negative for c-KIT and positive for antibody anti-DOG1.
    Epstein MG; Pasquetti AF; Costa SV; Favaro Mde L; Contrucci Filho O; Ribeiro Junior MA
    Einstein (Sao Paulo); 2012; 10(3):377-9. PubMed ID: 23386022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).
    Miwa S; Nakajima T; Murai Y; Takano Y; Sugiyama T
    J Gastroenterol; 2008; 43(7):531-7. PubMed ID: 18648740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of DOG-1 expression associated with shift from spindled to epithelioid morphology in gastric gastrointestinal stromal tumors with KIT and platelet-derived growth factor receptor α mutations.
    Agaimy A; Wang LM; Eck M; Haller F; Chetty R
    Ann Diagn Pathol; 2013 Apr; 17(2):187-91. PubMed ID: 23218903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes.
    Burger H; den Bakker MA; Kros JM; van Tol H; de Bruin AM; Oosterhuis W; van den Ingh HF; van der Harst E; de Schipper HP; Wiemer EA; Nooter K
    Cancer Biol Ther; 2005 Nov; 4(11):1270-4. PubMed ID: 16294026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.
    Koay MH; Goh YW; Iacopetta B; Grieu F; Segal A; Sterrett GF; Platten M; Spagnolo DV
    Pathology; 2005 Feb; 37(1):22-31. PubMed ID: 15875730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
    Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN
    Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new case of Carney triad: gastrointestinal stromal tumours and leiomyoma of the oesophagus do not show activating mutations of KIT and platelet-derived growth factor receptor alpha.
    Knop S; Schupp M; Wardelmann E; Stueker D; Horger MS; Kanz L; Einsele H; Kroeber SM
    J Clin Pathol; 2006 Oct; 59(10):1097-9. PubMed ID: 17021135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.